July 6, 2022: The Alexander Shulgin Research Institute and CaaMTech announce collaboration to study novel compounds from the Shulgin Vault. Shulgin compounds will be studied by X-ray diffraction crystallography at Dr. David Manke’s lab at UMass-Dartmouth.
June 3, 2022: The first clinical study of the safety, tolerability, and efficacy of DMT in Major Depressive Disorder employs DMT synthesized by ASRI scientists.
December 20, 2021: ASRI scientists help bring new clarity to psilocybin crystal polymorphs using X-ray diffraction crystallography.
December 9, 2021: ASRI raises $7.2 million in Seed financing round. Press release here.
April 19, 2021: The Alexander Shulgin Research Institute is incorporated by Ann Shulgin, Paul Daley, and Nicholas Cozzi. Happy Bicycle Day!
